Open main menu
Home
Random
Recent changes
Special pages
Community portal
Preferences
About Wikipedia
Disclaimers
Incubator escapee wiki
Search
User menu
Talk
Dark mode
Contributions
Create account
Log in
Editing
Transferrin
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
== Transferrin and nanomedicine == Many drugs are hindered when providing treatment when crossing the blood-brain barrier yielding poor uptake into areas of the brain. Transferrin glycoproteins are able to bypass the [[Blood–brain barrier|blood-brain barrier]] via receptor-mediated transport for specific transferrin receptors found in the brain capillary endothelial cells.<ref>{{cite journal | vauthors = Ghadiri M, Vasheghani-Farahani E, Atyabi F, Kobarfard F, Mohamadyar-Toupkanlou F, Hosseinkhani H | title = Transferrin-conjugated magnetic dextran-spermine nanoparticles for targeted drug transport across blood-brain barrier | journal = Journal of Biomedical Materials Research Part A | volume = 105 | issue = 10 | pages = 2851–2864 | date = October 2017 | pmid = 28639394 | doi = 10.1002/jbm.a.36145 }}</ref> Due to this functionality, it is theorized that [[Nanoparticles for drug delivery to the brain|nanoparticles]] acting as drug carriers bound to transferrin glycoproteins can penetrate the blood-brain barrier allowing these substances to reach the diseased cells in the brain.<ref>{{cite journal | vauthors = Gaspar R | title = Nanoparticles: Pushed off target with proteins | journal = Nature Nanotechnology | volume = 8 | issue = 2 | pages = 79–80 | date = February 2013 | pmid = 23380930 | doi = 10.1038/nnano.2013.11 | bibcode = 2013NatNa...8...79G }}</ref> Advances with transferrin conjugated nanoparticles can lead to non-invasive drug distribution in the brain with potential therapeutic consequences of [[central nervous system]] (CNS) targeted diseases (e.g. [[Alzheimer's disease|Alzheimer's]] or [[Parkinson's disease|Parkinson's]] disease).<ref>{{cite journal | vauthors = Li S, Peng Z, Dallman J, Baker J, Othman AM, Blackwelder PL, Leblanc RM | title = Crossing the blood-brain-barrier with transferrin conjugated carbon dots: A zebrafish model study | journal = Colloids and Surfaces B: Biointerfaces | volume = 145 | pages = 251–256 | date = September 2016 | pmid = 27187189 | doi = 10.1016/j.colsurfb.2016.05.007 | doi-access = free }}</ref>
Edit summary
(Briefly describe your changes)
By publishing changes, you agree to the
Terms of Use
, and you irrevocably agree to release your contribution under the
CC BY-SA 4.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)